Tracking molecular malfunctions in metastatic colorectal cancer to find new avenues for treatment

Scientists have identified a new mechanism behind immune evasion in metastatic colorectal cancer (mCRC), challenging a long-held theory about cancer. The research, a collaboration between Hokkaido University and an international team, could open up new avenues for treatment.